CAR-T Therapy Shows Promise in Treating Autoimmune Diseases in Children
A type of personalized cell therapy showed promising results in treating autoimmune disorders in children and adolescents, according to a report compiled from multiple news sources. The therapy, known as CAR-T cell therapy, appeared to reset the immune system and ease severe symptoms in eight children, as detailed in Nature News.
The research, highlighted in multiple reports, focused on the use of CAR-T cells to combat autoimmune diseases. These diseases occur when the immune system mistakenly attacks the body's own tissues. The CAR-T cell therapy involves modifying a patient's own immune cells to target and eliminate the harmful cells causing the autoimmune response.
According to Nature News, this therapy has shown potential in treating various autoimmune disorders. While specific details about the trial's timeline or the exact nature of the children's conditions were not provided in the source material, the report indicates a significant advancement in healthcare.
The news also highlighted other advancements in healthcare and technology. A nationwide NHS trial was underway, utilizing at-home technology to aid stroke recovery. This trial, as reported by BBC Technology, involved the largest brain stimulation study ever conducted, with approximately 270 participants. This technology offered the potential to restore independence for stroke survivors, who often experience long-term disabilities. The BBC Technology report also noted that stroke affects approximately 100,000 people annually in the UK.
The reports also touched on other areas, including the influence of longevity enthusiasts on vaccine guidelines and the emergence of high-tech heists. However, the primary focus remained on the advancements in cell therapy for autoimmune disorders in children and the innovative use of technology in stroke recovery.
Discussion
AI Experts & Community
Be the first to comment